High-Yield Summary
- Infected total knee arthroplasty (TKA) requires prompt, accurate diagnosis and tailored surgical management to optimize eradication and functional outcomes.
- One-stage exchange offers comparable infection control with fewer surgeries and faster recovery but demands strict patient selection and microbiological certainty.
- Two-stage exchange remains the gold standard for complex infections, resistant organismsor compromised hosts, balancing infection eradication with staged reconstruction.
- Key decision factors include pathogen virulence, soft tissue status, host immune competenceand implant fixation quality.
- Surgical success hinges on meticulous debridement, appropriate antibiotic deliveryand implant choice aligned with infection severity and patient factors.
Clinical Fundamentals
Anatomy and Biomechanics
The knee joint comprises the distal femur, proximal tibiaand patella, stabilized by collateral ligaments and the extensor mechanism. Total knee arthroplasty replaces these surfaces with metal and polyethylene components, restoring alignment and load transfer. Infection disrupts soft tissue integrity and bone stock, complicating implant fixation and joint biomechanics.
Epidemiology
Periprosthetic joint infection (PJI) complicates 1-2% of primary TKAs and up to 4% of revisions. Risk factors include obesity, diabetes, immunosuppression, prior surgeryand prolonged operative time. Early infections (<3 months) often present acutely, while late infections (>3 months) may be indolent with biofilm formation.
Classification & Diagnosis
| Classification System | Description | Impact on Management |
|---|---|---|
| Tsukayama Classification | Divides PJI into early postoperative, late chronic, acute hematogenousand positive intraoperative cultures | Guides timing and aggressiveness of intervention |
| Zimmerli Criteria | Defines PJI based on clinical signs, microbiology, histologyand synovial fluid analysis | Diagnostic gold standard for confirming infection |
| MSIS Criteria (2018) | Combines major and minor criteria including sinus tract, pathogen isolation, elevated ESR/CRP, synovial WBC countand neutrophil percentage | Standardizes diagnosis, reducing false positives/negatives |
Diagnostic Pearls
- Synovial fluid analysis with leukocyte count >3000 cells/?L and neutrophils >80% strongly suggests infection.
- Culture-negative PJI requires extended incubation and molecular diagnostics to avoid misclassification.
- Imaging (radiographs, nuclear scans) aids in assessing implant loosening but is nonspecific for infection.
- Avoid premature antibiotics before obtaining cultures to maximize yield.
Decision-Making Algorithm
| Criteria | Non-Operative Management | One-Stage Exchange | Two-Stage Exchange |
|---|---|---|---|
| Infection Duration | Acute hematogenous (<3 weeks) with stable implant | Chronic infection with known pathogen, good soft tissueand host | Chronic infection, unknown or resistant pathogen, poor soft tissue, immunocompromised host |
| Pathogen | Low virulence, antibiotic-sensitive | Identified pathogen with susceptibility | Resistant organisms (MRSA, fungi), polymicrobial |
| Host Factors | Medically unfit for surgery | Good immune status, minimal comorbidities | Poor host, multiple comorbidities |
| Soft Tissue | Intact, no sinus tract | Healthy soft tissue envelope | Sinus tract, compromised soft tissue |
| Implant Status | Stable implant | Well-fixed implant or planned removal | Loose implant requiring removal |
Rationale
Non-operative management is limited to acute infections with stable implants and early antibiotic therapy. One-stage exchange reduces morbidity and hospitalization but requires pathogen identification and optimal host conditions. Two-stage exchange prioritizes infection eradication in complex scenarios, allowing interim antibiotic spacer placement and staged reconstruction.
Surgical Mastery & Pearls
One-Stage Exchange Technique
- Perform extensive synovectomy and radical debridement of all infected and necrotic tissue.
- Remove all components and cement meticulously to eliminate biofilm reservoirs.
- Obtain multiple intraoperative cultures before irrigation.
- Use antibiotic-loaded cement tailored to pathogen sensitivities for reimplantation.
- Achieve stable fixation and restore alignment with appropriate implant choice.
- Intraoperative red flag: persistent purulence after debridement suggests need to abort one-stage and consider two-stage approach.
Two-Stage Exchange Technique
- Stage 1: Remove all implants and cement, perform aggressive debridement, place an articulating or static antibiotic spacer.
- Administer systemic antibiotics guided by culture results for 6 weeks.
- Monitor inflammatory markers and clinical signs to confirm infection control.
- Stage 2: Reimplant definitive prosthesis after infection eradication, reassess soft tissue and bone stock.
- Intraoperative red flag: elevated synovial WBC or persistent purulence at reimplantation mandates spacer retention or repeat debridement.
Technical Tips
- Use pulse lavage with copious saline to reduce bacterial load without damaging soft tissues.
- Avoid dead space by using antibiotic spacers that maintain joint mobility and soft tissue tension.
- Ensure multidisciplinary coordination with infectious disease specialists for antibiotic stewardship.
Evidence-Based Synthesis
Recent meta-analyses and randomized controlled trials have challenged the dogma favoring two-stage exchange as the universal standard. Studies demonstrate that one-stage exchange achieves comparable infection eradication rates (85-95%) with fewer surgeries, shorter hospital staysand improved functional outcomes in well-selected patients. However, heterogeneity in patient populations and pathogen profiles limits broad applicability.
Two-stage exchange remains superior in managing resistant organisms, polymicrobial infectionsand compromised hosts, with eradication rates exceeding 90%. Emerging data suggest that advances in microbiological diagnostics and antibiotic-loaded cement formulations may expand indications for one-stage exchange.
Controversies persist regarding optimal spacer design, timing of reimplantationand antibiotic duration. Current consensus emphasizes individualized treatment algorithms integrating host, pathogenand local tissue factors rather than a one-size-fits-all approach.
Master Class Pro-Tip
Mastery in managing infected TKA lies in the surgeon’s ability to integrate microbiological data with intraoperative findings dynamically. When performing a one-stage exchange, do not hesitate to convert to a two-stage strategy intraoperatively if debridement fails to achieve a clean field or unexpected resistant organisms emerge. This flexibility, combined with meticulous soft tissue handling and precise implant positioning, distinguishes the expert surgeon who consistently achieves durable infection control without compromising knee function.
